Tuesday, April 11, 2006

Mount Sinai launches combination therapy trial to treat relapsing-remitting Multiple Sclerosis

Mount Sinai launches combination therapy trial to treat relapsing-remitting Multiple Sclerosis
EurekAlert! Tue, 11 Apr 2006 7:36 AM PDT
New York, NY - Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis.

Epstein-Barr Virus Could Boost Multiple Sclerosis Risk
HealthDay via Yahoo! News Mon, 10 Apr 2006 1:02 PM PDT
MONDAY, April 10 (HealthDay News) -- Exposure to the Epstein-Barr virus, which often causes mononucleosis in young adults, may double the risk of developing multiple sclerosis (MS) 15 to 20 years later, researchers report.

Study links common virus to multiple sclerosis
Reuters via Yahoo! News Mon, 10 Apr 2006 1:44 PM PDT
Young adults whose immune systems react strongly when exposed to a common virus may run a higher risk of developing multiple sclerosis later in life, researchers reported on Monday.

Virus tied to multiple sclerosis in long-term study
Reuters via Yahoo! News Mon, 10 Apr 2006 2:33 PM PDT
Elevated blood levels of antibodies to Epstein-Barr virus (EBV) can be seen in multiple sclerosis (MS) patients decades before the onset of disease, according to a report published today.

Epstein-Barr virus infection linked to multiple sclerosis
News-Medical-Net Tue, 11 Apr 2006 2:03 AM PDT
Young adults with high levels of antibodies against the Epstein-Barr virus, the virus that most often causes mononucleosis, may be more likely to develop multiple sclerosis 15 to 20 years later, according to a study in the Archives of Neurology.

Virus linked to multiple sclerosis
Aljazeera Mon, 10 Apr 2006 7:02 PM PDT
Young adults, whose immune systems react strongly when exposed to a common virus, may run a higher risk of developing multiple sclerosis (MS) later in life, a new report has revealed.

Epstein-Barr Linked to Multiple Sclerosis
RedNova Mon, 10 Apr 2006 6:08 PM PDT
Young adults with high levels of antibodies against the Epstein-Barr virus may be more likely to develop multiple sclerosis, says a U.S. study.

Epstein-Barr Virus May Be Associated with Multiple Sclerosis
Newswise Mon, 10 Apr 2006 1:25 PM PDT
Young adults with high levels of antibodies against the Epstein-Barr virus, the virus that most often causes mononucleosis, may be more likely to develop multiple sclerosis 15 to 20 years later, according to a study posted online today that will appear in the June 2006 print issue of Archives of Neurology.

Epstein-Barr Virus Could Boost Multiple Sclerosis Risk
Health Scout Mon, 10 Apr 2006 2:05 PM PDT
A vaccine against the virus might also help prevent MS, experts say.

Epstein-Barr Virus May Trigger MS
WebMD Mon, 10 Apr 2006 1:48 PM PDT
Young adults with high levels of antibodies to Epstein-Barr virus appear to be at increased risk for developing multiple sclerosis later in life, new research suggests.

0 Comments:

Post a Comment

<< Home